コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 to control (15%+/-0.6 oleoresin, 6.4%+/-0.4 gingerol).
2 rption to simultaneously release ASA and [6]-gingerol.
3 was largely owing to 10-gingerol, but not 6-gingerol.
4 in the fresh ginger extract, followed by 10-gingerol.
5 t LTA(4)H might be a potential target of [6]-gingerol.
6 n vitro relative to the marker compound, [6]-gingerol.
7 dardized by HPLC to contain 17.0 mg/g of [6]-gingerol.
8 enhancement of candied mango by infusion of gingerols.
9 ocyanate (ITC), cinnamaldehyde, allicin, and gingerol].
10 n plcg1(-/-) mutants and show that ginger/10-gingerol (10-G) can rescue the expression of arterial an
11 ingerols infused product (GIP), with 3.67 mg gingerols/100 g and non-infused products (control) were
12 ed higher yield of oleoresin (20%+/-0.5) and gingerol (12.2%+/-0.4) compared to control (15%+/-0.6 ol
13 ract contained high TPC concentration, and 6-gingerol (44.57 mg/gDE), 8-gingerol (8.62 mg/gDE), and 6
14 action with ethanol provided higher yield of gingerol (6.2-6.3%) than the control (5.5%) with compara
16 ginger (Zingiber officinale Roscoe) viz. [6]-gingerol, [6]-shogaol and zingerone exhibited quorum sen
17 centration, and 6-gingerol (44.57 mg/gDE), 8-gingerol (8.62 mg/gDE), and 6-shogaol (6.92 mg/gDE).
20 pared with other ginger compounds, such as 6-gingerol and 6-shogaol, 6-DHSG showed the most potent an
21 related compounds of the ginger family, [6]-gingerol and [6]-paradol, on EGF-induced cell transforma
24 rase increased the yield of [6]-, [8]-, [10]-gingerols and [6]-shogaol by 64.10, 87.8, 62.78 and 32.0
25 Parameters optimized for maximum recovery of gingerols and [6]-shogaol were ammonium sulphate concent
26 Except for zingerone and 6-gingerol, other gingerols and shogaols at a concentration of 20 muM inhi
28 The pungent bioactive principles of ginger, gingerols and six other gingerol-related compounds were
29 These results suggest that phloretin and [6]-gingerol are potential dietary compounds that can allevi
31 thways such as "stilbenoid, diarylheptanoid, gingerol biosynthesis" were enriched in high weight rabb
34 The optimal MA: Glc-based extract with a 6-gingerol content of 1.90+/-0.05 mg/g, an antioxidant act
36 ficacy in cancer, the mechanism by which [6]-gingerol exerts its chemopreventive effects remains elus
39 pothesized that phloretin from apple and [6]-gingerol from ginger inhibit formation of AGEs and suppr
44 systematically optimized at bench-scale for gingerols infusion and subsequent candying treatment in
49 activities of fresh ginger extract and seven gingerol-related compounds on the neuro-inflammation wer
50 rinciples of ginger, gingerols and six other gingerol-related compounds were determined and identifie
51 (sensory (overall)) > k(total phenolics) > k(gingerols), resulting in multiple cutoff criteria and pr
53 rification of biologically active molecules (gingerols, shogaols and zingerone) contained in ginger.
54 rious biologically active molecules, such as gingerols, shogaols and zingerone, among others, are the
56 supported our prediction by showing that [6]-gingerol suppresses anchorage-independent cancer cell gr
57 also support the anticancer efficacy of [6]-gingerol targeting of LTA(4)H for the prevention of colo
62 anced the anti-neuroinflammatory capacity of gingerols yet, conversely, attenuated those of shogaols.